ROSENMAN HERM
SEC CIK 1230057 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | Dir | 5,927 | — | $28.19M | 30 | 2021-11-08 | 2026-06-26 |
Most active insiders at NTRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| 2 | Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| 3 | BOTHA ROELOF | Dir | — | $34.89M |
| 4 | RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| 5 | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| 6 | Sheena Jonathan | Dir, CO-FOUNDER | — | $22.83M |
| 7 | Brophy Michael Burkes | CFO | — | $22.14M |
| 8 | ROSENMAN HERM | Dir | — | $15.14M |
| 9 | Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| 10 | Baynes Roy D. | Dir | — | $2.81M |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-30 20:05 | 2026-06-26 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +1,677 | 5,927 | +39% | — |
| T | 2026-06-26 21:05 | 2026-06-24 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | S - Sale | $250.00 | -16.5K | 4,250 | -80% | -$4.13M |
| M | 2026-04-28 20:35 | 2026-04-24 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +339 | 20.8K | +2% | — |
| 2026-02-03 | 2026-01-30 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +99 | 20.4K | +0.5% | — | |
| M | 2025-12-16 | 2025-12-12 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | S - Sale | $227.42 | -48.4K | 20.3K | -70% | -$11.01M |
| 2025-12-16 | 2025-10-31 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +132 | 68.8K | +0.2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +153 | 68.6K | +0.2% | — | |
| M | 2025-07-01 | 2025-06-27 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +2,414 | 68.5K | +4% | — |
| 2025-04-29 | 2025-04-25 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +164 | 66.1K | +0.2% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +133 | 65.9K | +0.2% | — | |
| 2024-10-29 | 2024-10-25 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +178 | 65.8K | +0.3% | — | |
| 2024-07-30 | 2024-07-26 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +206 | 65.6K | +0.3% | — | |
| 2024-07-02 | 2024-06-28 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +2,964 | 65.4K | +5% | — | |
| M | 2024-04-30 | 2024-04-26 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +732 | 62.2K | +1% | — |
| D | 2024-02-16 | 2024-02-16 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | M - OptEx | $2.66 | +93.9K | 155.6K | +152% | +$249.8K |
| DM | 2024-02-16 | 2024-02-16 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | S - Sale+OE | $69.37 | -93.9K | 61.7K | -60% | -$6.51M |
| 2024-01-30 | 2024-01-26 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $63.79 | +303 | 61.7K | +0.5% | +$19.3K | |
| 2023-10-31 | 2023-10-27 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $42.60 | +454 | 61.4K | +0.7% | +$19.3K | |
| 2023-08-01 | 2023-07-28 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $48.48 | +380 | 60.9K | +0.6% | +$18.4K | |
| D | 2023-07-05 | 2023-06-30 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | — | +2,750 | 60.5K | +5% | — |
| D | 2023-05-26 | 2023-05-25 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | M - OptEx | — | +3,534 | 57.8K | +7% | — |
| 2023-04-18 | 2023-04-14 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $54.73 | +331 | 54.3K | +0.6% | +$18.1K | |
| 2023-01-18 | 2023-01-13 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $40.01 | +453 | 53.9K | +0.8% | +$18.1K | |
| 2022-10-18 | 2022-10-14 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $45.42 | +399 | 53.5K | +0.8% | +$18.1K | |
| A | 2022-09-02 | 2022-07-08 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | A - Grant | $0.00 | +499 | 53.1K | +0.9% | $0 |
| D | 2022-05-27 | 2022-05-25 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | M - OptEx | — | +1,307 | 52.6K | +3% | — |
| DA | 2021-11-09 | 2021-11-08 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | M - OptEx | $2.66 | +44.5K | 95.8K | +87% | +$118.4K |
| DMA | 2021-11-09 | 2021-11-08 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | S - Sale+OE | $117.39 | -44.5K | 51.3K | -46% | -$5.22M |
| DM | 2021-11-09 | 2021-11-08 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | S - Sale+OE | $29.38 | -44.5K | 54.5K | -45% | -$1.31M |
| D | 2021-11-09 | 2021-11-08 | NTRA | Natera, Inc. | ROSENMAN HERM | Dir | M - OptEx | $2.66 | +44.5K | 95.8K | +87% | +$118.4K |
Purchase Sale Sale after option exercise All abbreviations